Edwards Lifesciences Corporation
Edwards Lifesciences Corporation’s revenue for fiscal 2025 (year ended December 2025) was $6.1 billion, up 11.5% from fiscal 2024.
- Revenue
- +10.5%
- EPS
- +4.60%
- Free cash flow
- −1.84%
- Total debt
- +0.10%
Quarter to September 2026, against a year earlier
Follow EW
Alert me
Edwards Lifesciences Corporation (EW) P/S ratio
As of 6 November 2026, Edwards Lifesciences Corporation (EW) trades at a P/S ratio of 8.8×. Over the past ten years it has ranged from 5.6× (May 2015) to 16.0× (December 2021); the current reading is higher than 51% of that period. That is above the Medical Devices industry median of 2.7× and above the Healthcare sector median of 3.5×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 8.2× | 1.01% |
| FY2024 | 8.1× | (11.11%) |
| FY2023 | 9.2× | (11.14%) |
| FY2022 | 10.3× | (33.27%) |
| FY2021 | 15.4× | 19.17% |
| FY2020 | 12.9× | 15.89% |
| FY2019 | 11.2× | 29.81% |
| FY2018 | 8.6× | 25.67% |
| FY2017 | 6.8× | (0.23%) |
| FY2016 | 6.9× | 0.57% |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Sep 2026 | 7.5× | (6.91%) |
| Jun 2026 | 8.0× | 8.81% |
| Mar 2026 | 7.4× | (10.45%) |
| Dec 2025 | 8.2× | 6.32% |
| 43 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| PHG Koninklijke Philips N.V. compare | 1.4× |
| GEHC GE HealthCare Technologies Inc. compare | 1.7× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 2.3× |
| BSX Boston Scientific Corporation compare | 2.9× |
| MDT Medtronic PLC compare | 3.5× |
| STE STERIS plc compare | 4.0× |
| SYK Stryker Corporation compare | 4.7× |
| DXCM DexCom, Inc. compare | 5.8× |
| EW Edwards Lifesciences Corporation | 8.8× |
| Medical Devices industry median | 2.7× |
| Healthcare sector median | 3.5× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on EW
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement